Nick Diamond Speaks on Vaccine Development at National Vaccine Law Conference

September 15, 2022 | Speaking Engagements

On September 15, 2022, Jackson Walker partner Nicholas J. Diamond presented two sessions at the National Vaccine Law Conference held at George Mason University’s Antonin Scalia Law School.

The first session, “International Vaccine Law,” covered international structures for the development, regulation, and distribution of vaccines. The presentation also discussed the topics of trade, supply chain issues, and intellectual property barriers for vaccine development and access. Fellow speakers included:

  • Fazal Khan (University of Georgia School of Law)
  • Clint Hermes (Bass, Berry & Sims)
  • Chizoba Wonodi (leader of Johns Hopkins Bloomberg School of Public Health Vaccine Access Center’s immunization support efforts in Nigeria)
  • John D. Winter (Patterson Belknap)

The second session, “The Bright Future of Vaccine Development,” discusses the legal implications of vaccines under development for conditions like HIV, cancer, Parkinson’s disease, Alzheimer’s disease, and drug addiction. Fellow panelists included:

  • Alexandra Bhatti (Director of U.S. Vaccine Policy at Merck & Co. Inc)
  • Richard Hughes IV (GW Milken Institute School of Public Health)

To learn more, visit the National Vaccine Law Conference website.

Nick DiamondMeet Nick

Nicholas J. Diamond is internationally recognized for his experience in vaccine law and public policy. He has extensive experience counseling vaccine manufacturers in the U.S., APAC, Latin America, and the EU on regulatory, public policy, government procurement and financing, liability and compensation, intellectual property, and international trade matters. He has counseled several vaccine manufacturers on highly significant product launches in recent years. He has also counseled other entities, such as healthcare payers and providers, including retail pharmacies, on vaccine-related matters involving coverage and reimbursement, contracting, scope of practice, liability, and public health emergency measures.

Nick is widely published internationally on issues spanning global health law, bioethics, business and human rights, public international law, and international investment law. His writing has been published in law reviews, peer-reviewed journals, and major media outlets, as well as discussed or featured in major media outlets, including The Washington Post, Slate, and Forbes. Nick has given invited talks in various academic and industry fora, and has frequently appeared as a commentator on national news networks, such as Bloomberg and MSNBC.